Grace Therapeutics, Inc. (ACST)
2.30
0.00 (0.00%)
USD |
NASDAQ |
Jun 08, 16:00
Grace Therapeutics EPS Diluted (Quarterly) : -0.1367 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 0.3861 |
| Abeona Therapeutics, Inc. | -0.3016 |
| Acumen Pharmaceuticals, Inc. | -0.328 |
| Abpro Holdings, Inc. | -0.2289 |
| Aardvark Therapeutics, Inc. | -0.9896 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.315M |
| Total Expenses (Quarterly) | 2.315M |
| Enterprise Value | 16.92M |
| Earnings Yield | -15.67% |
| Normalized Earnings Yield | -23.25 |